Đang chuẩn bị liên kết để tải về tài liệu:
Clinical outcome of patients with pancreatic metastases from renal cell cancer

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Renal cell cancer (RCC) is one of the most frequent primary sites for metastatic pancreatic tumors although metastatic tumors are rare among pancreatic malignant tumors. The purpose of this study is to disclose the characterization and treatment outcomes of pancreatic metastases from RCC. |

TÀI LIỆU LIÊN QUAN

Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy

Improving the assessment of quality of life in the clinical care of myeloma patients: The development and validation of the Myeloma Patient Outcome Scale (MyPOS)

Association between red blood cell storage duration and clinical outcome in patients undergoing off-pump coronary artery bypass surgery: A retrospective study

Clinical outcome after surgery for lumbar spinal stenosis in patients with insignificant lower extremity pain: A prospective cohort study from the Norwegian registry for spine surgery

Aberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients

Distribution, dynamic evolution, and clinical outcomes of patients with advanced breast cancer according to HER2 expression

Clinical outcome of treatment of metastatic non-small cell lung cancer in patients harboring uncommon EGFR mutation

Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain

Clinical outcome of patients with pancreatic metastases from renal cell cancer

báo cáo khoa học:" Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease"